Physician profile
Hui Chen
NPI 1891056677
$2,164.73
in general payments reported to CMS, 2019-2025
14 companies · $1,165 in 2025
The $1,165 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2021: $214 · 2022: $179 · 2023: $230 · 2024: $265 · 2025: $1,165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,065 · Food and Beverage: $595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,064.50 |
| Food and Beverage | $595.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,141.43 | 2022-2025 | |
| Glaxosmithkline, LLC. | $296.68 | 2021-2024 | Jemperli, Zejula |
| Caris Mpi, INC. | $136.88 | 2025 | Mi Cancer Seek |
| Janssen Biotech, INC. | $112.80 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $103.00 | 2021 | |
| Beigene USA, INC. | $102.32 | 2023 | Brukinsa |
| Abbvie INC. | $78.60 | 2024 | |
| Aadi Bioscience, INC. | $58.11 | 2023 | Fyarro |
| Seagen INC. | $43.37 | 2022 | |
| Emd Serono, INC. | $41.25 | 2023 | Mavenclad |
| Merck Sharp & Dohme LLC | $21.70 | 2022 | |
| Immunogen, INC. | $15.45 | 2023 | Elahere |
| Medical Device Business Services, INC. | $13.14 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hui Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.